CTS (Therapeutic Devices) Overview
- Founded
-
1997

- Status
-
Out of Business
- Employees
-
3

- Latest Deal Type
-
Out of Business
CTS (Therapeutic Devices) General Information
Description
Developer of a molecular imaging platform designed to detect cancer. The company's platform develops clinical products for cancer imaging and therapeutics and its core proprietary technology is based on gene which are specifically triggered inside cancer cells which are based on cell-specific gene promoters, enabling patients to detect early-stage cancer and start treatment according to it and also can be freeze-dried for long-term storage without losing efficacy and rapidly reconstituted for easy administration.
Contact Information
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Diagnostic Equipment
Primary Office
- The Mansion
- Chesterford Research Park
- Cambridge CB10 1XL
- England, United Kingdom
+44 01799 000000
CTS (Therapeutic Devices) Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 01-Apr-2019 | 00.00 | Completed | Out of Business | ||
2. PE Growth/Expansion | 17-Sep-2014 | 00.00 | 00.00 | Completed | Generating Revenue | |
1. Accelerator/Incubator | Completed | Startup |
CTS (Therapeutic Devices) Patents
CTS (Therapeutic Devices) Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3781130-A4 | Therapeutic constructs for treating cancer | Pending | 11-Apr-2018 | 000000000 | |
EP-3781130-A1 | Therapeutic constructs for treating cancer | Pending | 11-Apr-2018 | 000000000 | |
US-20210154328-A1 | Therapeutic constructs for treating cancer | Pending | 11-Apr-2018 | C12N15/85 |